Cargando…
Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma
IMPORTANCE: A blood-based screening tool for detecting diffuse glioma is necessary to improve clinical outcomes. OBJECTIVES: To establish models using serum microRNAs to distinguish patients with diffuse glioma from control individuals without cancer (the Glioma Index) and to differentiate glioblast...
Autores principales: | Ohno, Makoto, Matsuzaki, Juntaro, Kawauchi, Junpei, Aoki, Yoshiaki, Miura, Junichiro, Takizawa, Satoko, Kato, Ken, Sakamoto, Hiromi, Matsushita, Yuko, Takahashi, Masamichi, Miyakita, Yasuji, Ichimura, Koichi, Narita, Yoshitaka, Ochiya, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902771/ https://www.ncbi.nlm.nih.gov/pubmed/31808923 http://dx.doi.org/10.1001/jamanetworkopen.2019.16953 |
Ejemplares similares
-
HGG-39. CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH RADIATION-INDUCED GLIOMA
por: Ohno, Makoto, et al.
Publicado: (2020) -
Brain metastasis-related microRNAs in patients with advanced breast cancer
por: Sato, Jun, et al.
Publicado: (2019) -
MPC-11 IDH1/2 MUTATIONS ARE ASSOCIATED WITH SEIZURE ONSET AND VETRY IMAGING IN PATIENTS WITH DIFFUSE GLIOMA VISUALIZING 2-HYDROXYGLUTARATE BY MASS SPECTRUM
por: Ohno, Makoto, et al.
Publicado: (2019) -
Assessment of therapeutic outcome and role of reirradiation in patients with radiation-induced glioma
por: Ohno, Makoto, et al.
Publicado: (2022) -
Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
por: Ohno, Makoto, et al.
Publicado: (2019)